Cite
HARVARD Citation
Popoff, E. et al. (2021). Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine. Headache. 61 (6), pp. 906-915. [Online].